Want to see HK:2616 full AI Analyst Report?
CStone Pharmaceuticals (2616) Ownership - Who Owns CStone Pharmaceuticals?
CStone Pharmaceuticals (2616) Ownership Overview
- 2.66% Mutual Funds
- 4.44% ETFs
- 92.90% Public Companies and Individual Investors
The ownership structure of CStone Pharmaceuticals (HK:2616) stock is a mix of institutional, retail, and individual investors. Approximately 7.10% of the company’s stock is owned by Institutional Investors, and 92.90% is owned by Public Companies and Individual Investors.
The ownership structure of CStone Pharmaceuticals (HK:2616) stock is a mix of institutional, retail, and individual investors. Approximately 7.10% of the company’s stock is owned by Institutional Investors, and 92.90% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 42,358,500 | Institution | 2.65% | 26,643,497 |
| Ishares | 25,566,500 | Institution | 1.60% | 16,081,329 |
| Vanguard International Equity Index Funds | 23,418,000 | Institution | 1.47% | 14,729,922 |
| Vanguard Star Funds | 18,244,500 | Institution | 1.14% | 11,475,791 |
| State Street | 2,342,500 | Institution | 0.15% | 1,473,433 |
| Fidelity Salem Street Trust | 619,500 | Institution | 0.04% | 389,666 |
| Spdr | 436,500 | Institution | 0.03% | 274,559 |
| State Street Institutional Investment Trust | 228,500 | Institution | 0.01% | 143,727 |
| L&g | 84,000 | Institution | <0.01% | 52,836 |
| Northern Trust | 22,500 | Institution | <0.01% | 14,153 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard International Equity Index Funds | 23,418,000 | Institution | 1.47% | 14,729,922 |
| Vanguard Star Funds | 18,244,500 | Institution | 1.14% | 11,475,791 |
| Fidelity Salem Street Trust | 619,500 | Institution | 0.04% | 389,666 |
| State Street Institutional Investment Trust | 228,500 | Institution | 0.01% | 143,727 |
| Franklin Alternative Strategies Funds | 1 | Institution | 0.00% | 1 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXUS ETF | 18,438,500 | Institution | 1.16% | 13,787,798 |
| Vanguard, VWO ETF | 17,740,000 | Institution | 1.11% | 13,265,479 |
| iShares, IEMG ETF | 13,263,000 | Institution | 0.83% | 8,037,310 |
| Vanguard, VSS ETF | 4,620,500 | Institution | 0.29% | 3,455,079 |
| State Street, SPEM ETF | 1,375,500 | Institution | 0.09% | 830,024 |
| Vanguard, VT ETF | 1,179,000 | Institution | 0.07% | 881,623 |
| iShares, IXUS ETF | 921,000 | Institution | 0.06% | 558,121 |
| State Street, EWX ETF | 693,500 | Institution | 0.04% | 418,482 |
| iShares, GB:SEDM ETF | 658,500 | Institution | 0.04% | 397,362 |
| iShares, ECNS ETF | 471,000 | Institution | 0.03% | 296,400 |
FAQ
What percentage of CStone Pharmaceuticals (HK:2616) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.10% of CStone Pharmaceuticals (HK:2616) stock is held by institutional investors: 2.66% by mutual funds and 4.44% by ETFs.
What percentage of CStone Pharmaceuticals (HK:2616) stock is held by retail investors?
According to the latest TipRanks data, approximately 92.90% of CStone Pharmaceuticals (HK:2616) stock is held by public companies and individual investors.
Who owns the most shares of CStone Pharmaceuticals (HK:2616)?
Vanguard owns the most shares of CStone Pharmaceuticals (HK:2616).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
